NCT02351128View on ClinicalTrials.gov

Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 15, 2017

Study Completion Date

May 15, 2017

Conditions
Carcinoma, Merkel Cell
Interventions
DRUG

Lanreotide

Trial Locations (1)

38 000

Grenoble University Hospital, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT02351128 - Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues | Biotech Hunter | Biotech Hunter